The German peptide therapeutics market will see a considerable growth of 5.0% during the forecast period. As per the report published by the German Diabetes Center (DDZ), in 2019 more than 7.2% of the population in Germany suffered from diabetes, most of them suffering from Type 2 diabetes. The report estimates that the number of individuals with diabetes will increase significantly in the next two decades.
Scientists at DDZ and the Robert Koch Institute (RKI) in Berlin predict that in 20 years from 2019, up to 12 million people in Germany could have Type 2 diabetes. If these estimates are correct, it would correspond to an increase in the number of up to 77.0% between 2015 and 2040. The rise in demand for insulin is anticipated to drive the growth of the peptide therapeutics market in Germany.
A full report of German Peptide Therapeutics Market is available at: https://www.omrglobal.com/industry-reports/german-peptide-therapeutics-market
Osteoarthritis is the most frequently occurring joint disorder in Germany. As per the German Health Interview and Examination Survey for Adults (DEGS1) held in 2017, 22.3% of women and 19.7% of men were suffering from osteoarthritis in Germany. Risk factors included increasing age, genetic predisposition, obesity, and overloading straining of the joints due to congenital deformities.
The increasing prevalence of osteoarthritis in Germany and the introduction of innovative biologics for the treatment of osteoarthritis are the two key factors that contribute to the growth of the peptide therapeutics market in Germany, thus, it expects to have stable growth in the country.
To learn more about this report request a sample copy @ https://www.omrglobal.com/request-sample/german-peptide-therapeutics-market
Market Coverage
- Study Period- 2019-2026
- Base year- 2019
- Forecast period- 2020-2026
- Segments Covered- By Route of Administration and By Application
- Key Companies Profiled- Novo Nordisk A/S, AstraZeneca Plc, CordenPharma International GmbH, Bachem Holding AG, and Sanofi SA
Key questions addressed by the report
- What is the market growth rate during the forecast period?
- Which segment/region dominates the market in the base year?
- Which segment/region will project the fastest growth in the market during the forecast period?
- Who is the leader in the market?
- How players are addressing challenges to sustain growth?
- Where is the investment opportunity?
German Peptide Therapeutics Market – Segmentation
By Route of Administration
- Oral
- Parenteral
By Application
- Cancer
- Gastrointestinal Disorders
- Central Nervous System Disorders
- Respiratory Disorders
- Others
This release has been published on OMR Industry Journal. OMR Industry Journal is not responsible for any content included in this release.
